MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Continuous subcutaneous levodopa/carbidopa infusion with ND0612 for Parkinson’s disease: Three-year data from the open-label BeyoND study

    W. Poewe, A. Ellenbogen, F. Stocchi, L. Adar, L. Salin, R. Case, T. Yardeni, N. Giladi (Innsbruck, Austria)

    Objective: To evaluate three-year outcomes from the ND0612 BeyoND study. Background: Investigational ND0612 is in development as a 24-hour continuous, subcutaneous infusion of liquid levodopa/carbidopa…
  • 2023 International Congress

    Motor evaluation of Parkinson disease and Vascular parkinsonism using the TUG encephalog application

    L. Franken, J. Reiner, M. Mermelstein, D. Biederko, R. Djaldettti (Petah Tikva, Israel)

    Objective: We aimed to compare gait and parkinsonian features between PD patients, VP patients and PD patients with Vascular component (PDVC) using a smartphone-based motion…
  • 2023 International Congress

    Pilot study to investigate the use of monopolar sensing to improve the efficiency of DBS programming in Parkinson’s disease

    J. Thompson, S. Ojemann, D. Kramer, E. Radcliffe, L. Hirt, M. Case, A. Becker, C. Zarns, R. Raike, A. Baumgartner, K. Kern (Aurora, USA)

    Objective: Compare the use of in-clinic monopolar sensing functionality and standard of care monopolar review for identifying optimal settings for deep brain stimulation in Parkinson’s…
  • 2023 International Congress

    iCARE-PD: a multinational multicenter feasibility study of Integrated Care Networks in Parkinson disease

    D. Dash, D. Grimes, J. Saade, R. Bouça, J. Ferreira, E. Ruzicka, A. Sanchez-Ferro, T. Lynch, M. van Munster, D. Pedrosa, M. Fabbri, O. Rascol, T. Mestre ()

    Objective: To evaluate the implementation of a novel pragmatic care delivery model for people living with Parkinson’s disease (PwP) Background: The intrinsic complexity of care…
  • 2023 International Congress

    Pain Phenomenon in Parkinson Disease

    R. Pinzon (Yogyakarta, Indonesia)

    Objective: To describe the phenomenon of pain disorder in Parkinson Disease patients. Background: Pain is one of the most common non-motor symptoms of Parkinson’s Disease…
  • 2023 International Congress

    The investigation of a novel video game for identifying mild cognitive impairment in individuals with Parkinson’s disease

    K. Carey, G. Postma, B. Trokthi, C. Maitland (Corinth, USA)

    Objective: To develop a novel video game (VG) prototype that can effectively detect mild cognitive impairment (MCI) in Parkinson’s disease (PD) patients. Background: MCI is…
  • 2023 International Congress

    Is cognitive function related to daily life gait and turning in people with Parkinson’s disease?

    M. Mancini, P. Burgos, P. Carlson-Kuhta, C. Silva-Batista, A. Ragothaman, V. Shah, F. Horak (Portland, USA)

    Objective: We investigated whether cognition and daily-life mobility are associated in people with mild-to-moderate Parkinson's disease (PD). Background: PD is responsible for more mobility disability…
  • 2023 International Congress

    Diagnostic Utility of Blood α-Synuclein in Parkinson’s Disease: A Systematic Review and Meta-analysis

    D. Su, L. Luo, J. Lam, T. Feng (Beijing, China)

    Objective: The aims were to (1) explore the concentration differences of α-syn species in different blood components between PD and healthy controls (HC), and between…
  • 2023 International Congress

    Making Parkinson’s care complete and global: an international survey of the “vitals” dashboard of Parkinson’s disease

    M. Qamar, C. Falup-Pecurariu, L. Batzu, A. Podlewska, S. Rota, N. Titova, V. Metta, I. Murasan, D. Ziemele, R. van Coller, J. Carr, G. Chung-Faye, L. Ungureanu, K. Ray Chaudhuri (London, United Kingdom)

    Objective: In this observational survey, we report on a multicentre dataset addressing whether such vitals are being routinely assessed. Background: Parkinson’s disease (PD), considered a…
  • 2023 International Congress

    Computerized cognitive training in advanced Parkinson’s disease: preliminary feasibility data of an ongoing randomized controlled trial

    P. Olgemöller, E. Kalbe, C. Hennen, M. Barbe, M. Hellmich, AK. Folkerts (Cologne, Germany)

    Objective: To analyse the feasibility and effects on cognitive- and non-cognitive outcomes, and prediction of responsiveness of a computerized cognitive training (CT) in comparison to…
  • « Previous Page
  • 1
  • …
  • 145
  • 146
  • 147
  • 148
  • 149
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley